In collaboration with leading academic medical centers, Amae Health delivers precision medicine and integrated care for complex mental health conditions across every stage of recovery, combining advanced science, clinical excellence, and compassionate design. Backed by 8VC.
About the role
You will report to and partner directly with Amae's founder and CEO to develop our first life sciences partnerships. You will own the day-to-day commercial process, while our Chief Medical Officer, CTO, and clinical and research teams help assess feasibility, develop scientific scope, and deliver the work. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Open doors. Build a focused target list with the CEO and secure meetings with relevant pharma and biotech decision-makers. Draw on existing relationships where useful, but be equally effective opening new accounts
- Typically 7+ years in life sciences business development, partnerships, or related commercial roles, with substantial hands-on experience selling to pharma or biotech
- Experience creating opportunities while the offering, buyer, or use case was still being defined, rather than relying on a mature product and established sales motion
- Demonstrated ability to gain access to relevant decision-makers, build relationships from scratch, identify budget owners, and navigate complex pharma buying processes
- Commercial judgment to explore medical affairs, HEOR, R&D, commercial, and other functions without assuming in advance where the strongest demand will be
- Strong commercial execution, including meeting preparation, persistent follow-through, proposals, negotiation, and the ability to sustain momentum through long, multi-stakeholder sales cycles
More about this role
Severe mental illness affects over 15 million adults in the United States. Schizophrenia. Schizoaffective disorder. Bipolar I. Treatment-resistant depression. These are the conditions the rest of healthcare has systematically failed to build for.
What makes this problem different from most of healthcare is that the tools to solve it do not exist. The clinical protocols, the measurement science, the precision medicine, the technology to deliver coordinated longitudinal outpatient care for this population. None of it has been built. This is a frontier problem, and it requires frontier science and care delivery to solve.
We are developing all of it. The care, the science, the technology.
The Problem
Schizophrenia and schizoaffective disorder, bipolar I disorder, and treatment-resistant depression are where psychiatry needs new therapies most, and where drug development has struggled most. Trials fight high placebo response and endpoints built on infrequent rating scales. After launch, there is little real-world evidence on what happens to patients once a prescription is written.
The missing piece is the care setting itself: a place where these patients are seen several times a week,...
Browse similar: Startup jobs · San Francisco Bay Area